DOI QR코드

DOI QR Code

Association Between XRCC1 Gene Polymorphisms and Risk of Glioma Development: A Meta-analysis

  • Sun, Jian-Ying ;
  • Zhang, Chun-Yang ;
  • Zhang, Zhen-Jun ;
  • Dong, Yan-Fang ;
  • Zhang, An-Long ;
  • Wang, Zhi-Wei ;
  • Mei, Xiao-Long
  • Published : 2012.09.30

Abstract

Objective: Previous studies of the association between X-ray cross-complementing group 1 (XRCC1) gene polymorphisms and the gliomas risk have yielded conflicting results, and thus a meta-analysis was performed to provide a more accurate estimation. Methods: A computerized literature search of 5 electronic databases was conducted to identify the relevant studies. Fixed or random effect models were selected based on the heterogeneity test. Publication bias was estimated using Begg's funnel plots and Egger's regression test. Results: A total of 11 studies (3,810 cases and 6,079 controls), 7 studies (2,928 cases and 5,048 controls), and 4 studies (1,461 cases and 2,593 controls) were finally included in the analyses of the association between XRCC1 Arg399Gln, Arg194Trp, and Arg280His polymorphisms and glioma risk, respectively. The pooled results showed that GlnGln carriage was associated with moderately increased risk of gliomas in Asians (GlnGln vs. ArgArg, OR=1.490, 95%CI 1.031-2.153; GlnGln/ArgGln vs. ArgArg, OR=1.321, 95%CI 1.037-1.684), whereas a marginal association was revealed in Caucasians. For the Arg194Trp polymorphism, although a significant association was shown in the homozygous genotype comparisons (TrpTrp vs. ArgArg, OR = 2.209, 95%CI 1.398-2.945), no significant link was found on subgroup analysis stratified by ethnicity. With regard to the Arg280His polymorphism, no significant association was found in each comparison. No particular study was found to significantly influence the pooled results, and no potential publication bias was detected. Conclusions: This meta-analysis suggested that the XRCC1 Arg399Gln polymorphism is moderately associated with increased risk of gliomas in Asians, while Arg194Trp and Arg280His polymorphisms demonstrated no significant influence. Due to the limited studies and the potential confounders, further studies are needed to confirm these results.

Keywords

XRCC1;DNA repair gene;gliomas;gene polymorphism

References

  1. Audebert M, Salles B, Calsou P (2004). Involvement of poly (ADP-ribose) polymerase-1 and XRCC1/DNA ligase III in an alternative route for DNA double-strand breaks rejoining. J Biol Chem, 279, 55117-26. https://doi.org/10.1074/jbc.M404524200
  2. Brem R, Hall J (2005). XRCC1 is required for DNA single-strand break repair in human cells. Nucleic Acids Res, 33, 2512-20. https://doi.org/10.1093/nar/gki543
  3. Caldecott KW (2003). XRCC1 and DNA strand break repair. DNA Repair (Amst), 2, 955-69. https://doi.org/10.1016/S1568-7864(03)00118-6
  4. Caldecott KW, Aoufouchi S, Johnson P, Shall S (1996). XRCC1 polypeptide interacts with DNA polymerase ${\beta}$ and possibly poly (ADP-ribose) polymerase, and DNA ligase III is a novel molecular 'nick-sensor'in vitro. Nucleic Acids Res, 24, 4387-94. https://doi.org/10.1093/nar/24.22.4387
  5. Caldecott KW, McKeown CK, Tucker JD, Ljungquist S, Thompson LH (1994). An interaction between the mammalian DNA repair protein XRCC1 and DNA ligase III. Mol Cell Biol, 14, 68-76.
  6. Custodio AC, Almeida LO, Pinto GR, et al (2011). Analysis of the polymorphisms XRCC1Arg194Trp and XRCC1Arg399Gln in gliomas. Genet Mol Res, 10, 1120-9. https://doi.org/10.4238/vol10-2gmr1125
  7. Custodio AC, Almeida LO, Pinto GR, et al (2012). Variation in DNA repair gene XRCC3 affects susceptibility to astrocytomas and glioblastomas. Genet Mol Res, 11, 332-9. https://doi.org/10.4238/2012.February.10.4
  8. Duell EJ, Wiencke JK, Cheng TJ, et al (2000). Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells. Carcinogenesis, 21, 965-71. https://doi.org/10.1093/carcin/21.5.965
  9. Felini MJ, Olshan AF, Schroeder JC, et al (2007). DNA repair polymorphisms XRCC1 and MGMT and risk of adult gliomas. Neuroepidemiology, 29, 55-8. https://doi.org/10.1159/000108919
  10. Goode EL, Ulrich CM, Potter JD (2002). Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev, 11, 1513-30.
  11. Harbord RM, Egger M, Sterne JA (2006). A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med, 25, 3443-57. https://doi.org/10.1002/sim.2380
  12. Higgins JP, Thompson SG (2002). Quantifying heterogeneity in a meta-analysis. Stat Med, 21, 1539-58. https://doi.org/10.1002/sim.1186
  13. Hu XB, Feng Z, Fan YC, Xiong ZY, Huang QW (2011). Polymorphisms in DNA repair gene XRCC1 and increased genetic susceptibility to glioma. Asian Pac J Cancer Prev, 12, 2981-4.
  14. Kiuru A, Lindholm C, Heinavaara S, et al (2008). XRCC1 and XRCC3 variants and risk of glioma and meningioma. J Neurooncol, 88, 135-42. https://doi.org/10.1007/s11060-008-9556-y
  15. Kyritsis AP, Bondy ML, Rao JS, Sioka C (2010). Inherited predisposition to glioma. Neuro Oncol, 12, 104-13. https://doi.org/10.1093/neuonc/nop011
  16. Liu JM, Sun H, Huang LW, Hu P, Dai XC (2011). Relationship between XRRC1 polymorphisms and adult gliomas. Mod Prev Med, 38, 3340-1.
  17. Liu Y, Scheurer ME, El-Zein R, et al (2009). Association and interactions between DNA repair gene polymorphisms and adult glioma. Cancer Epidemiol Biomarkers Prev, 18, 204-14. https://doi.org/10.1158/1055-9965.EPI-08-0632
  18. Liu Y, Zhou K, Zhang H, et al (2008). Polymorphisms of LIG4 and XRCC4 involved in the NHEJ pathway interact to modify risk of glioma. Hum Mutat, 29, 381-9. https://doi.org/10.1002/humu.20645
  19. Masson M, Niedergang C, Schreiber V, et al (1998). XRCC1 is specifically associated with poly (ADP-ribose) polymerase and negatively regulates its activity following DNA damage. Mol Cell Biol, 18, 3563-71.
  20. McKean-Cowdin R, Barnholtz-Sloan J, Inskip PD, et al (2009). Associations between polymorphisms in DNA repair genes and glioblastoma. Cancer Epidemiol Biomarkers Prev, 18, 1118-26. https://doi.org/10.1158/1055-9965.EPI-08-1078
  21. Rajaraman P, Hutchinson A, Wichner S, et al (2010). DNA repair gene polymorphisms and risk of adult meningioma, glioma, and acoustic neuroma. Neuro Oncol, 12, 37-48. https://doi.org/10.1093/neuonc/nop012
  22. Sathornsumetee S, Reardon DA, Desjardins A, et al (2007). Molecularly targeted therapy for malignant glioma. Cancer, 110, 13-24. https://doi.org/10.1002/cncr.22741
  23. Schwartzbaum JA, Fisher JL, Aldape KD, Wrensch M (2006). Epidemiology and molecular pathology of glioma. Nature Clin Prac Neurol, 2, 494-503.
  24. Taylor RM, Thistlethwaite A, Caldecott KW (2002). Central role for the XRCC1 BRCT I domain in mammalian DNA singlestrand break repair. Mol Cell Biol, 22, 2556-63. https://doi.org/10.1128/MCB.22.8.2556-2563.2002
  25. Tobias A (1999). Assessing the influence of a single study in the meta-analysis estimate. Stata Tech Bull, 47, 15-7.
  26. Tudek B (2007). Base excision repair modulation as a risk factor for human cancers. Mol Aspects Med, 28, 258-75. https://doi.org/10.1016/j.mam.2007.05.003
  27. Wang LE, Bondy ML, Shen H, et al (2004). Polymorphisms of DNA repair genes and risk of glioma. Cancer Res, 64, 5560-3. https://doi.org/10.1158/0008-5472.CAN-03-2181
  28. Wong HK, Wilson DM, 3rd (2005). XRCC1 and DNA polymerase beta interaction contributes to cellular alkylating-agent resistance and single-strand break repair. J Cell Biochem, 95, 794-804. https://doi.org/10.1002/jcb.20448
  29. Yosunkaya E, Kucukyuruk B, Onaran I, et al (2010). Glioma risk associates with polymorphisms of DNA repair genes, XRCC1 and PARP1. Br J Neurosurg, 24, 561-5. https://doi.org/10.3109/02688697.2010.489655
  30. Zhou LQ, Ma Z, Shi XF, et al (2011). Polymorphisms of DNA repair gene XRCC1 and risk of glioma: a case-control study in Southern China. Asian Pac J Cancer Prev, 12, 2547-50.

Cited by

  1. Association Between Genetic Polymorphism of XRCC1 Gene and Risk of Glioma in а Chinese Population vol.14, pp.10, 2013, https://doi.org/10.7314/APJCP.2013.14.10.5957
  2. Associations between three XRCC1 polymorphisms and glioma risk: a meta-analysis vol.34, pp.5, 2013, https://doi.org/10.1007/s13277-013-0865-1
  3. Association between the XRCC1 Polymorphisms and Glioma Risk: A Meta-Analysis of Case-Control Studies vol.8, pp.1, 2013, https://doi.org/10.1371/journal.pone.0055597
  4. Association between DNA repair gene polymorphisms and risk of glioma: A systematic review and meta-analysis vol.16, pp.6, 2014, https://doi.org/10.1093/neuonc/nou003
  5. Genetic polymorphisms in XRCC1 gene and susceptibility to glioma in Chinese Han population vol.35, pp.1, 2014, https://doi.org/10.1007/s13277-013-1050-2
  6. Three polymorphisms of DNA repair gene XRCC1 and the risk of glioma: a case–control study in northwest China vol.35, pp.2, 2014, https://doi.org/10.1007/s13277-013-1191-3
  7. DNA repair gene ERCC1 polymorphisms may contribute to the risk of glioma vol.35, pp.5, 2014, https://doi.org/10.1007/s13277-013-1557-6
  8. Letter regarding Zhu et al. entitled “Assessment of the association between XRCC1 Arg399Gln polymorphism and glioma susceptibility” vol.35, pp.7, 2014, https://doi.org/10.1007/s13277-014-1931-z
  9. XRCC1 Gene Polymorphisms and Glioma Risk in Chinese Population: A Meta-Analysis vol.9, pp.11, 2014, https://doi.org/10.1371/journal.pone.0111981
  10. DNA repair gene XRCC3 Thr241Met polymorphism and susceptibility to glioma: A case-control study vol.8, pp.2, 2014, https://doi.org/10.3892/ol.2014.2192